This protein acts a positive regulator, increasing exocytotic FPN trafficking and decreasing endocytic trafficking of FPN at rest, suggesting that its pharmacological inhibition results in iron improvement in hemochromatosis [322]. The gene discussed is SLC40A1; the disease is hemochromatosis.